Literature DB >> 33108066

Clinical aspects of a large group of adults with Angelman syndrome.

Inge den Besten1, Rianne F de Jong1, Amber Geerts-Haages1, Hennie T Bruggenwirth2, Marije Koopmans3, Alice Brooks2, Ype Elgersma4, Dederieke A M Festen1, Marlies J Valstar1,5.   

Abstract

Descriptions of the clinical features of Angelman syndrome (AS) have mainly been focused on children. Here, we describe the evolution of the clinical phenotypes of AS in adulthood, using clinical data from 95 individuals (mean age 31.6 years, median 29.0 years, range 18-83 years), with genetically confirmed AS. Data was collected through physical examination and inspection of medical records, combined with questionnaires and interviews. Adults with AS experience substantial debilitating health problems. Constipation, reflux, visual problems, scoliosis, behavioral and sleeping problems occurred frequently and require appropriate attention. Epilepsy was reported in 57% of adults, negatively affecting the level of functioning. Non-convulsive status epilepticus was not observed in the adults, however some individuals developed prolonged episodes of rhythmic shaking while awake. A decline in mobility was noted in the majority of adults. A minority of adults with AS showed microcephaly. Taken together, this first phenotypic study of adults with AS to include in person interviews with care-givers and physical examination of patients, including the eldest adult reported to date, provides important insight in the development of the syndrome into adulthood. This knowledge is required to improve care for adult individuals with AS and to evaluate future therapies for this group.
© 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Entities:  

Keywords:  Angelman syndrome; UBE3A; clinical spectrum; intellectual disability; natural history

Mesh:

Year:  2020        PMID: 33108066      PMCID: PMC7756639          DOI: 10.1002/ajmg.a.61940

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  55 in total

Review 1.  [Multiple births in the Netherlands].

Authors:  Tina J Glasner; Catharina E M van Beijsterveldt; Gonneke Willemsen; Dorret I Boomsma
Journal:  Ned Tijdschr Geneeskd       Date:  2013

2.  Problem behaviors associated with 15q- Angelman syndrome.

Authors:  D J Clarke; G Marston
Journal:  Am J Ment Retard       Date:  2000-01

3.  Diagnostic uses of the Vineland Adaptive Behavior Scales.

Authors:  S S Sparrow; D V Cicchetti
Journal:  J Pediatr Psychol       Date:  1985-06

Review 4.  Neurologic manifestations of Angelman syndrome.

Authors:  Ronald L Thibert; Anna M Larson; David T Hsieh; Annabel R Raby; Elizabeth A Thiele
Journal:  Pediatr Neurol       Date:  2013-04       Impact factor: 3.372

5.  Angelman syndrome: are the estimates too low?

Authors:  R H Buckley; N Dinno; P Weber
Journal:  Am J Med Genet       Date:  1998-12-04

6.  Angelman syndrome in Denmark. birth incidence, genetic findings, and age at diagnosis.

Authors:  Line Granild Bie Mertz; Rikke Christensen; Ida Vogel; Jens Michael Hertz; Karen Brøndum Nielsen; Karen Grønskov; John R Østergaard
Journal:  Am J Med Genet A       Date:  2013-08-02       Impact factor: 2.802

Review 7.  Angelman syndrome: a review of the clinical and genetic aspects.

Authors:  J Clayton-Smith; L Laan
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

8.  Retinochoroidal atrophy in two adult patients with Angelman syndrome.

Authors:  A Rufa; M T Dotti; A Orrico; C Battisti; F Carletto; A Federico
Journal:  Am J Med Genet A       Date:  2003-10-01       Impact factor: 2.802

9.  Molecular screening for proximal 15q abnormalities in a mentally retarded population.

Authors:  J Jacobsen; B H King; B L Leventhal; S L Christian; D H Ledbetter; E H Cook
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

10.  Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation.

Authors:  C A Williams; H Angelman; J Clayton-Smith; D J Driscoll; J E Hendrickson; J H Knoll; R E Magenis; A Schinzel; J Wagstaff; E M Whidden
Journal:  Am J Med Genet       Date:  1995-03-27
View more
  3 in total

Review 1.  UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome.

Authors:  Ype Elgersma; Monica Sonzogni
Journal:  Dev Med Child Neurol       Date:  2021-02-04       Impact factor: 5.449

2.  Double paternal uniparental isodisomy 7 and 15 presenting with Beckwith-Wiedemann spectrum features.

Authors:  Siren Berland; Cecilie F Rustad; Mariann H L Bentsen; Embjørg J Wollen; Gitta Turowski; Stefan Johansson; Gunnar Houge; Bjørn I Haukanes
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-12-09

3.  Clinical aspects of a large group of adults with Angelman syndrome.

Authors:  Inge den Besten; Rianne F de Jong; Amber Geerts-Haages; Hennie T Bruggenwirth; Marije Koopmans; Alice Brooks; Ype Elgersma; Dederieke A M Festen; Marlies J Valstar
Journal:  Am J Med Genet A       Date:  2020-10-27       Impact factor: 2.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.